论文部分内容阅读
1998年,上海医药系统的员工,克服了资金紧缺、市场竞争激烈、出口受阻以及连续高温等困难,继续保持了健康和快速的发展。 在45个制药企业中,工业总产值比上年增长的有33家,占73.3％,比上年减少的有12家,占26.7％。从工业总产值的增幅来看,居增幅前10位的企业是:强生(增长239％),先灵葆雅(增长209.2％),思富(增长104％),罗氏(增长76.8％),斯米克(增长76.2％),先锋(增长75％),福
In 1998, employees of the Shanghai Pharmaceutical System overcame difficulties in the shortage of funds, fierce market competition, blocked exports and continued high temperatures, and continued to maintain healthy and rapid development. Among the 45 pharmaceutical companies, the total industrial output value increased by 33 over the previous year, accounting for 73.3%, which was a decrease of 12 from the previous year, accounting for 26.7%. Judging from the increase in gross industrial output value, the top 10 companies in the increase are: Johnson & Johnson (up 239%), Schering-Plough (a growth of 209.2%), SI (a growth of 104%), Roche (a growth of 76.8%), and Smic (a growth 76.2%), Pioneer (up 75%), Fu